Jürgen Wess and Liu Liu for their study on A novel function of the M2 muscarinic receptor Drs.

GPCR Summit 2022 is less than a month away!

February 2022 "Switzerland Today, InterAx Biotech is pleased to announce that Carola Weiss has joined Carola Weiss is a Senior Executive with more than 20 years of international experience in the biopharmaceutical Carola Weiss ’ professional career brings deep expertise in business development, marketing & sales,

Jurgen Wess’s lab at the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) - NIH,

Juergen Wess - Postdoc and Group leader in Aventis, now Sanofi, Frankfurt, Germany - Head of in vitro

Because BAMs engage less well-conserved allosteric sites and exert pathway-specific effects on receptor